| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.16 | 0.0004 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.15 | 0.0007 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.083 | 0.08 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.041 | 0.4 |